Biofermin Pharmaceutical. (4517.TSE) Q3 2018 Earnings

25OctExpected
Q4 2017
Q1 2018
Q2 2018
Q3 2018
32.95
44.08
55.2
66.33

Details

Expected EPS
N/A
Actual EPS
49.8701
Surprise EPS
49.87
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 49.8701 per share for Q3 2018.

0 Comments

Share your thoughts